Publication:
Steven's johnson syndrome and toxic epidermal necrolysis in children

dc.contributor.buuauthorTuran, Hakan
dc.contributor.buuauthorVatansever, Sevgül
dc.contributor.buuauthorÖzdemir, Özlem
dc.contributor.buuauthorCanitez, Yakup
dc.contributor.buuauthorCANITEZ, YAKUP
dc.contributor.buuauthorSarmaoglu, Hayriye
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.
dc.date.accessioned2024-10-03T10:26:23Z
dc.date.available2024-10-03T10:26:23Z
dc.date.issued2008-12-01
dc.description.abstractAim: The aim of this study was to consider clinical features, laboratory findings, treatment alternatives, complications and responsible agents of Steven's Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in childhood.Materials and Method: The patients who were diagnosed with Steven's Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) and followed by Department of Dermatology, Division of Pediatric Neurology and Division of Pediatric Allergy of Uludag University Faculty of Medicine, between 2000-2008 were evaluated retrospectively.Results: Records of 14 patients (7 females/7 males) were examined, Nine of the patients had SJS, 2 had SJS-TEN overlap syndrome and the rest 3 had TEN. Nine patients had history of using drugs for epilepsy and the others for anxiety, tooth abscess, cryptic tonsillitis, otitis media and bronchiolitis, Eleven of the patients (78.5%) had multiple drug intake. In 7 patients (50%) Lamotrigine (4 of 7 patients was also taken Valproic acid) and in other patients oxcarbamazepine, azytromicine, phenytoin, imipra mine, cefuroxime axetil, ciprofloxacin, ceftriaxone were responsible for SJS and TEN. Twelve 13atients were treated with systemic corticosteroid and 2 vvith intravenous All of the patierits vvere cured.Conclosion: Although drug reactions were seen less frequently ill childreri coniipared to adults,. it nitist be taken.. into ci3risideration that there is the risk i3f developing severe drug reactions like SJS and TEN in children who have been using such drugs for a long time or using multipl drugs for extended periods.
dc.identifier.endpage110
dc.identifier.issn1304-9054
dc.identifier.issue3
dc.identifier.startpage104
dc.identifier.urihttps://hdl.handle.net/11452/45783
dc.identifier.volume6
dc.identifier.wos000422250500005
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.journalGuncel Pediatri-journal Of Current Pediatrics
dc.subjectSteven's johnson syndrome
dc.subjectToxic epidermal necrolysis
dc.subjectChildren
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectPediatrics
dc.titleSteven's johnson syndrome and toxic epidermal necrolysis in children
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication6b5d010e-4bcd-498b-8e2c-3d59ff1edb47
relation.isAuthorOfPublication.latestForDiscovery6b5d010e-4bcd-498b-8e2c-3d59ff1edb47

Files

Collections